The global human growth hormone treatment and drugs market is experiencing strong growth, valued at USD 3.67 billion in 2023 and set to reach approximately USD 5.26 billion by 2033. With a robust Compound Annual Growth Rate (CAGR) of 3.7%, the sector is benefiting from an increasing demand driven by rising prevalence of health conditions associated with hGH deficiencies, such as Prader-Willi syndrome, Turner syndrome, and idiopathic short stature (ISS).
The Vital Role of Human Growth Hormone in Healthcare
Human growth hormone, or somatotropin, plays a crucial role in human development, responsible for stimulating growth, cell regeneration, and reproduction. Deficiencies in hGH, often caused by the pituitary gland’s inadequate production, can result in significant developmental challenges, including short stature and delayed puberty. These conditions are increasingly being managed through hGH treatments, creating a growing market for both pharmaceutical companies and healthcare providers.
Ethical Considerations Amid Growing Demand
As the demand for hGH therapies increases, concerns over its misuse in non-medical applications have emerged. Particularly in bodybuilding, sports, and anti-aging circles, hGH is being used outside its approved indications. However, the U.S. Food and Drug Administration (USFDA) has not approved hGH for anti-aging or performance-enhancing purposes, categorizing these uses as prohibited. The medical community is actively working to promote the responsible and ethical use of hGH, emphasizing its intended therapeutic applications and discouraging misuse.
Key Market Drivers and Industry Growth
The rise in conditions associated with hGH deficiency is a major factor driving the growth of the market. Both younger and aging populations are increasingly affected, and awareness of the benefits of hGH therapy is growing among healthcare providers and patients alike. The increased availability of hGH medications has also made it easier for individuals to access these essential treatments, further contributing to the expansion of the market.
Future Outlook and Opportunities
The global hGH market presents significant opportunities for collaboration across the healthcare sector. By promoting understanding of hGH’s approved medical uses and working to prevent its misuse, stakeholders can ensure the hormone is utilized ethically, ensuring sustainable market growth and maintaining patient trust. As the market continues to evolve, healthcare providers and manufacturers alike will play a pivotal role in shaping the future of hGH treatment.
Key Takeaways: Human Growth Hormone Treatment and Drugs Market (2023-2033)
- The global Human Growth Hormone Treatment and Drugs Market is expected to reach a value of around USD 5.26 billion by 2033, reflecting a steady growth at a Compound Annual Growth Rate (CAGR) of 3.7% from 2023 to 2033.
- Growth Drivers:
- Increasing geriatric population with growth in hormone replacement therapies.
- Rising awareness about growth hormone deficiencies and their treatment options.
- Growing investments in research and development (R&D) for novel Human Growth Hormone (HGH) therapies.
- Expanding government initiatives supporting hormone therapies.
- Market Potential: A robust product pipeline, diversification of treatment options, and increasing focus on patient well-being are expected to propel market growth further.
“A healthy product portfolio and extensive Market research investments for the emergence of future growth hormone treatments are projected to propel the sales of human growth hormone treatment & drugs.”
Increased Market Demand: Get In-Depth Analysis and Insights with Our Complete Report!
Competitive Landscape:
Advancements in the development of more efficient chemical formulations are poised to boost the demand for adult human growth hormone injections, benefiting market participants. Leading companies in this sector are actively pursuing mergers and acquisitions to extend their market presence and ramp up the production of human growth hormone injections.
- In February 2022, Pfizer Inc. and OPKO Health, Inc. introduced NGENLA, a once-weekly injection of a long-acting recombinant human growth hormone authorized by the European Commission. This injection is indicated for treating inadequate growth hormone secretion from infancy up to adolescence.
- Additionally, in 2021, the US Food and Drug Administration (FDA) approved Eli Lilly’s product Verzenio (abemaciclib), a CDK4/6 inhibitor for high-risk early breast cancer with HR+ HER2- status.
Key Companies Profiled:
- Ankebio Co. Ltd.
- Eli Lilly and Company
- Emd Serono
- Ferring Pharmaceuticals
- Genentech Inc.
- Gene Science Pharmaceutical Co. Ltd.
- Ipsen, LG Life Sciences
- Merck KGaA
- Novo Nordisk
- Ascendis Pharma
- Pfizer Inc.
Key Market Segments Covered in Human Growth Hormone Treatment and Drugs Market Industry:
By Route of Administration:
- Subcutaneous
- Intramuscular
- Intravenous
- Oral
By Application:
- Growth Hormone Deficiency
- Turner Syndrome
- Idiopathic Short Stature (ISS)
- Prader-Willi Syndrome (PWS)
- Other Applications
By Distribution Channel:
- Hospital Pharmacy
- Specialty Pharmacy
- Retail Pharmacy
- Online Pharmacy
By Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- The Middle East and Africa (MEA)
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube